Occult tumour cells in peritoneal lavage are a negative prognostic factor in pancreatic cancer
Language English Country Czech Republic Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
23128819
DOI
10.5507/bp.2012.061
Knihovny.cz E-resources
- MeSH
- Adenocarcinoma mortality pathology MeSH
- Ascitic Fluid cytology MeSH
- Adult MeSH
- ErbB Receptors metabolism MeSH
- Carcinoembryonic Antigen metabolism MeSH
- Middle Aged MeSH
- Humans MeSH
- Neoplasm Recurrence, Local metabolism mortality MeSH
- Biomarkers, Tumor metabolism MeSH
- Pancreatic Neoplasms mortality pathology MeSH
- Disease-Free Survival MeSH
- Prognosis MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Telomerase metabolism MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- ErbB Receptors MeSH
- Carcinoembryonic Antigen MeSH
- Biomarkers, Tumor MeSH
- Telomerase MeSH
- TERT protein, human MeSH Browser
AIMS: The aim of this study was to test the hypothesis that occult tumour cells in peritoneal lavage are a negative prognostic factor in pancreatic adenocarcinoma. METHODS: Real-time RT-PCR analysis of CEA, EGFR and hTERT transcript levels was used to identify occult tumour cells in peritoneal lavage samples from 96 pancreatic cancer patients. RESULTS: We found significant association between CEA expression levels in peritoneal lavage and clinical stage. We also found that EGFR transcript levels were higher in peritoneal lavage samples from patients with high grade tumours than in samples from patients with low grade tumours. Detection of CEA and/or EGFR occult tumour cell markers in the peritoneal lavage was associated with significantly shorter overall survival and increased hazard ratio for disease recurrence. CONCLUSIONS: The results show that the presence of occult tumour cells in peritoneal lavage is a negative prognostic factor for survival in pancreatic cancer patients, and that detection of occult tumour cells using PCR-based methods can identify patients with advanced disease for whom radical surgery is likely to have little benefit.
References provided by Crossref.org
Recent Advances in Methods for Circulating Tumor Cell Detection